10-Q Filing

ENZON PHARMACEUTICALS, INC. CIK: 727510 Q2 2016

Filing Information

Form Type	10-Q
Accession Number	`0001144204-16-118076`
Period End Date	20160630
Filing Date	20160810
Fiscal Year	2016
Fiscal Period	Q2
XBRL Instance	enzn-20160630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 50 Income Statement 48 Cash Flow Statement 26

Balance Sheet 50 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$34.56M	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$11.23M	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$38.99M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$11.67M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$278.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$107.00K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Total current assets	`AssetsCurrent`	$11.78M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$11.51M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Deferred tax assets, net	`DeferredTaxAssetsLiabilitiesNetNoncurrent`	$9.28M	USD	Point-in-time
Deferred tax assets, net	`DeferredTaxAssetsLiabilitiesNetNoncurrent`	$11.11M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	170.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	170.00M	shares	Point-in-time
Total assets	`Assets`	$20.79M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	43.87M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	44.21M	shares	Point-in-time
Total assets	`Assets`	$22.89M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	43.87M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	44.21M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	-	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$90.00K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$150.00K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$205.00K	USD	Point-in-time
Accrued lease termination costs	`AccruedLeaseTerminationCostsCurrent`	$4.51M	USD	Point-in-time
Accrued lease termination costs	`AccruedLeaseTerminationCostsCurrent`	-	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$150.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.80M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock - $0.01 par value, authorized 3,000,000 shares; no shares issued and outstanding at June 30, 2016 and December 31, 2015	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock - $0.01 par value, authorized 3,000,000 shares; no shares issued and outstanding at June 30, 2016 and December 31, 2015	`PreferredStockValue`	-	USD	Point-in-time
Common stock - $0.01 par value, authorized 170,000,000 shares; issued and outstanding 43,866,611 and 44,214,603 shares at June 30, 2016 and December 31, 2015, respectively	`CommonStockValue`	$441.00K	USD	Point-in-time
Common stock - $0.01 par value, authorized 170,000,000 shares; issued and outstanding 43,866,611 and 44,214,603 shares at June 30, 2016 and December 31, 2015, respectively	`CommonStockValue`	$439.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$96.91M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$96.92M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-76.71M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-79.27M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$18.09M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$20.64M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$22.89M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$20.79M	USD	Point-in-time

Income Statement 48 line items

Line Item	Tag	Value	Unit	Period
Royalties	`RoyaltyRevenue`	$10.30M	USD	2 Qtrs
Royalties	`RoyaltyRevenue`	$5.50M	USD	2 Qtrs
Royalties	`RoyaltyRevenue`	$2.27M	USD	1 Quarter
Royalties	`RoyaltyRevenue`	$5.10M	USD	1 Quarter
Miscellaneous income	`OtherSalesRevenueNet`	$42.00K	USD	2 Qtrs
Miscellaneous income	`OtherSalesRevenueNet`	$151.00K	USD	2 Qtrs
Miscellaneous income	`OtherSalesRevenueNet`	-	USD	1 Quarter
Miscellaneous income	`OtherSalesRevenueNet`	$95.00K	USD	1 Quarter
Total revenues	`SalesRevenueNet`	$10.45M	USD	2 Qtrs
Total revenues	`SalesRevenueNet`	$5.54M	USD	2 Qtrs
Total revenues	`SalesRevenueNet`	$2.27M	USD	1 Quarter
Total revenues	`SalesRevenueNet`	$5.19M	USD	1 Quarter
General and administrative	`OtherGeneralAndAdministrativeExpense`	$516.00K	USD	1 Quarter
General and administrative	`OtherGeneralAndAdministrativeExpense`	$436.00K	USD	1 Quarter
General and administrative	`OtherGeneralAndAdministrativeExpense`	$1.16M	USD	2 Qtrs
General and administrative	`OtherGeneralAndAdministrativeExpense`	$1.10M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$1.16M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$436.00K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$516.00K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$1.10M	USD	2 Qtrs
Operating income and income before income tax expense (benefit)	`OperatingIncomeLoss`	$4.38M	USD	2 Qtrs
Operating income and income before income tax expense (benefit)	`OperatingIncomeLoss`	$4.68M	USD	1 Quarter
Operating income and income before income tax expense (benefit)	`OperatingIncomeLoss`	$9.35M	USD	2 Qtrs
Operating income and income before income tax expense (benefit)	`OperatingIncomeLoss`	$1.84M	USD	1 Quarter
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$894.00K	USD	1 Quarter
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$-1.60M	USD	2 Qtrs
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$1.83M	USD	2 Qtrs
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$801.00K	USD	1 Quarter
Net income	`NetIncomeLoss`	$10.95M	USD	2 Qtrs
Net income	`NetIncomeLoss`	$3.78M	USD	1 Quarter
Net income	`NetIncomeLoss`	$1.03M	USD	1 Quarter
Net income	`NetIncomeLoss`	$2.55M	USD	2 Qtrs
Basic	`EarningsPerShareBasic`	$0.02	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.06	USD	2 Qtrs
Basic	`EarningsPerShareBasic`	$0.25	USD	2 Qtrs
Basic	`EarningsPerShareBasic`	$0.09	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.09	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.06	USD	2 Qtrs
Diluted	`EarningsPerShareDiluted`	$0.25	USD	2 Qtrs
Diluted	`EarningsPerShareDiluted`	$0.02	USD	1 Quarter
Weighted-average shares - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	44.18M	shares	1 Quarter
Weighted-average shares - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	44.17M	shares	2 Qtrs
Weighted-average shares - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	44.18M	shares	2 Qtrs
Weighted-average shares - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	44.12M	shares	1 Quarter
Weighted-average shares - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	44.12M	shares	1 Quarter
Weighted-average shares - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	44.23M	shares	2 Qtrs
Weighted-average shares - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	44.17M	shares	2 Qtrs
Weighted-average shares - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	44.22M	shares	1 Quarter

Cash Flow Statement 26 line items

Line Item	Tag	Value	Unit	Period
Net income	`NetIncomeLoss`	$10.95M	USD	2 Qtrs
Net income	`NetIncomeLoss`	$3.78M	USD	1 Quarter
Net income	`NetIncomeLoss`	$1.03M	USD	1 Quarter
Net income	`NetIncomeLoss`	$2.55M	USD	2 Qtrs
Deferred tax expense (benefit)	`DeferredIncomeTaxExpenseBenefit`	$-1.68M	USD	2 Qtrs
Deferred tax expense (benefit)	`DeferredIncomeTaxExpenseBenefit`	$1.83M	USD	2 Qtrs
Changes in operating assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$4.82M	USD	2 Qtrs
Changes in operating assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$418.00K	USD	2 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$8.85M	USD	2 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-441.00K	USD	2 Qtrs
Withholding taxes - stock-based compensation	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	-	USD	2 Qtrs
Withholding taxes - stock-based compensation	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$6.00K	USD	2 Qtrs
Common stock dividend	`PaymentsOfDividendsCommonStock`	-	USD	2 Qtrs
Common stock dividend	`PaymentsOfDividendsCommonStock`	$4.42M	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-4.42M	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	-	USD	2 Qtrs
Net increase (decrease) in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-441.00K	USD	2 Qtrs
Net increase (decrease) in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$4.43M	USD	2 Qtrs
Cash at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$34.56M	USD	Point-in-time
Cash at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$11.23M	USD	Point-in-time
Cash at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$38.99M	USD	Point-in-time
Cash at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$11.67M	USD	Point-in-time
Cash at end of period	`CashAndCashEquivalentsAtCarryingValue`	$34.56M	USD	Point-in-time
Cash at end of period	`CashAndCashEquivalentsAtCarryingValue`	$11.23M	USD	Point-in-time
Cash at end of period	`CashAndCashEquivalentsAtCarryingValue`	$38.99M	USD	Point-in-time
Cash at end of period	`CashAndCashEquivalentsAtCarryingValue`	$11.67M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.